Advertisement

Digestive Diseases and Sciences

, Volume 55, Issue 12, pp 3430–3435 | Cite as

Characteristics and Outcomes of Upper Gastrointestinal Hemorrhage in a Tertiary Referral Hospital

  • Magnus HallandEmail author
  • Melissa Young
  • Michael N. Fitzgerald
  • Kerry Inder
  • John M. Duggan
  • Anne Duggan
Original Article

Abstract

Background and Aims

Upper gastrointestinal hemorrhage remains a problem in spite of improved diagnosis and management. There is sparse knowledge of recent epidemiology and outcomes. We wanted to evaluate the characteristics and outcomes of patients with upper gastrointestinal hemorrhage over a 4-year period in a tertiary referral hospital.

Methods

We prospectively collected data on patients admitted with upper gastrointestinal hemorrhage to John Hunter Hospital between August 2004 and December 2008. Variables of interest included age, gender, co-morbidities, and time to endoscopy. Main outcomes included etiology, treatment, and survival. Variceal and non-variceal bleeds were analyzed separately.

Results

There were 792 admissions from 734 unique patients (61% male) with a mean age of 66 years. The most frequent causes of non-variceal bleeds (88%) included ulcers 265 (33%); Mallory Weiss tear 91 (11%); esophagitis 60 (8%), and malignancy 29 (4%). Most patients had one or more co-morbidity (74%). Transfusion was not employed in 41%. Overall mortality was 4.0% (5.4% in the variceal and 3.9% in the non-variceal group). Only 1.9% of patients had surgery.

Conclusions

Patients presenting with upper gastrointestinal hemorrhage are overall elderly with significant co-morbidities. Our overall mortality and surgery rates are lower than in previously published international data.

Keywords

Audit Upper gastrointestinal bleeding Gastric and duodenal ulcers Epidemiology 

Abbreviations

ANOVA

Analysis of variance

JHH

John Hunter Hospital

NSAIDs

Non-steroidal anti-inflammatory drugs

PPI

Proton pump inhibitor

SD

Standard deviation

UGIH

Upper gastrointestinal hemorrhage

Notes

Acknowledgments

The authors would like to thank the medical, nursing, and allied health staff whose skills made this study possible.

Funding

Public hospital audit; No external sponsorship, grants or funding.

References

  1. 1.
    Barkun AN. Should every patient with suspected upper GI bleeding receive a proton pump inhibitor while awaiting endoscopy? Gastrointest Endosc. 2008;67:1064–1066.CrossRefPubMedGoogle Scholar
  2. 2.
    Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol. 2009;7:33–47.CrossRefGoogle Scholar
  3. 3.
    Duggan JM. Review article: transfusion in gastrointestinal haemorrhage—if, when and how much? Aliment Pharmacol Ther. 2001;15:1109–1113.CrossRefPubMedGoogle Scholar
  4. 4.
    Jordan PH Jr. Surgery for peptic ulcer disease. Curr Probl Surg. 1991;28:265–330.PubMedGoogle Scholar
  5. 5.
    Hamoui N, Docherty SD, Crookers PF. Gastrointestinal hemorrhae: is the surgeon obsolete. Emerg Med Clin of NA. 2003;21:1017–1056.CrossRefGoogle Scholar
  6. 6.
    Rockall TA, Logan RF, Devlin HB, Northfield TC. Influencing the practice and outcome in upper gastrointestinal haemorrhage. Gut. 1997;41:606–611.CrossRefPubMedGoogle Scholar
  7. 7.
    Thomopoulos K, Theochais G, Mimidis K, et al. Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of short- and long-term outcome. Dig Liver Dis. 2006;38:899–904.CrossRefPubMedGoogle Scholar
  8. 8.
    Theocharis G, Thomopoulos K, Sakellaropoulos G, et al. Changing trends in the epidemiology and clinical outcome of acute upper gastrointestinal bleeding in a defined geographical area in Greece. J Clin Gastroenterol. 2008;42:128–133.CrossRefPubMedGoogle Scholar
  9. 9.
    Rockall TA, Logan RFA, Devlin HB, Blatchford M, Pell J. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ. 1997;315:510–514.Google Scholar
  10. 10.
    Tsesmeli NE, Kotsaftis PS, Savopoulos CG, Hatzitolios A, et al. Incidence and etiology of acute non-malignant upper gastrointestinal bleeding in northern Greece. Gastroenterology. 2007;22:1009–1013.Google Scholar
  11. 11.
    Fiore FD, Lecleire S, Merle V, Herve S, Duhamel C, et al. Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: a comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study. Eur J Gastroenterol. 2005;17:641–647.CrossRefGoogle Scholar
  12. 12.
    Rofe SB, Duggan JM, Smith ER, et al. Conservative treatment of gastrointestinal haemorrhage. Gut. 1985;26:481–484.CrossRefPubMedGoogle Scholar
  13. 13.
    Chapman BL, Duggan JM. Aspirin and uncomplicated peptic ulcer. Gut. 1969;10:443–450.CrossRefPubMedGoogle Scholar
  14. 14.
    Andriulli A, Loperfido S, Focareta R, et al. High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study. Am J Gastroenterol. 2008;103:3011–3018.CrossRefPubMedGoogle Scholar
  15. 15.
    SAS/STAT Software Version 9.1 (SAS Institute Inc., Cary, NC, USA).Google Scholar
  16. 16.
    Rockall TA, Logan RF, Devlin HB. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316–321.CrossRefPubMedGoogle Scholar
  17. 17.
    Gidding HF, Topp L, Middleton M, et al. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997–2006. J Gastroenterol Hepatol. 2009;24:1648–1654.CrossRefPubMedGoogle Scholar
  18. 18.
    Alcohol consumption per capita 1996–2003. Australian Bureau of Statistics. http://www.abs.gov.au/ausstats/abs@.nsf/ProductsbyReleaseDate/E02E0094E2F974AECA25702C00816B50?OpenDocument Accessed March 05, 2010.
  19. 19.
    Sadic J, Borgstrom A, Manjer J, Toth E, Lindell G. Bleeding peptic ulcer–time trends in incidence, treatment and mortality in Sweden. Aliment Pharmacol Ther. 2009;30:392–398.CrossRefPubMedGoogle Scholar
  20. 20.
    Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther. 1995;9:45–51.PubMedGoogle Scholar
  21. 21.
    Visser LE, Graatsma HH, Stricker BHC. Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol. 2002;53:183–188.CrossRefPubMedGoogle Scholar
  22. 22.
    Dorward S, Sreedharan A, Leontiadis GI et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2006; Oct 18 (4):CD005415.Google Scholar
  23. 23.
    Blair SD, Janvrin SB, McCollum CM, Greenhalg RM. Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg. 1986;73:783–785.CrossRefPubMedGoogle Scholar
  24. 24.
    Beecher HK. Resuscitation in men severely wounded in battle. In: De Bakey ME, ed. Surgery in WWII in Vol 11 General Surgery. Washington: Office of the Surgeon General, Dept. of the Army; 1955:3–39.Google Scholar
  25. 25.
    Bickell WH, Bruttig SP, Millnamow GA, O’Benar J, Wade CE. Immediate versus delayed resuscitation in hypotensive patients with penetrating torso injuries. N Eng J Med. 1994;331:1105–1109.CrossRefGoogle Scholar
  26. 26.
    UK comparative audit of upper gastrointestinal bleeding and the use of blood. December 2007. St Elsewhere’s NHS foundation trust. http://www.bsg.org.uk/pdf_word_docs/blood_audit_report_07.pdf. Accessed January 21, 2010.
  27. 27.
    Duggan JM. Haemetemasis patients should be managed in special unit. MJA. 1986;144:247–250.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Magnus Halland
    • 1
    Email author
  • Melissa Young
    • 1
  • Michael N. Fitzgerald
    • 2
  • Kerry Inder
    • 2
  • John M. Duggan
    • 1
  • Anne Duggan
    • 1
  1. 1.Department of GastroenterologyJohn Hunter HospitalNew Lambton, NewcastleAustralia
  2. 2.Centre for Clinical Epidemiology and BiostatisticsUniversity of NewcastleNewcastleAustralia

Personalised recommendations